Cardiorenal metabolic syndrome in the African diaspora: Rationale for including chronic kidney disease in the metabolic syndrome definition

Ethnicity and Disease

Volumn 19, Issue 2 SUPPL.2, 2009, Pages

  Lea, Janice P ^a   Greene, Eddie L ^b   Nicholas, Susanne B ^c   Agodoa, Lawrence ^e   Norris, Keith C ^c,d  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Cardiovascular disease; Chronic kidney disease; Ethnic; Metabolic syndrome

Indexed keywords

AFRICAN AMERICAN; CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; HUMAN; INSULIN RESISTANCE; METABOLIC SYNDROME X; MICROALBUMINURIA; RISK; CHRONIC DISEASE; ETHNOLOGY; GLOMERULUS FILTRATION RATE; KIDNEY DISEASE; REVIEW; STATISTICS;

AFRICAN AMERICANS; CHRONIC DISEASE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; METABOLIC SYNDROME X;

EID: 80053181684     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. US Renal Data System. USRDS 2007 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, Md: National Institute of Diabetes and Digestive and Kidney Diseases; 2007.
2. Alberti KG, Zimmer PZ. Definition, diagnosis and classification of diabetes mellitus and its complications: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539-553. (Pubitemid 28319935)
3. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106: 3143-3421.
4. Ford ES, Giles WH, Dietz WH. Prevalence of metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-359. (Pubitemid 34251969)
5. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis. 2002;39(Suppl): S1-S266.
6. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296-1305.
7. Palaniappan L, Carnethon M, Fortmann SP. Association between microalbuminuria and metabolic syndrome: NHANES III. Am J Hypertens. 2003;16:952-958. (Pubitemid 37315495)
8. Hoehner CM, Greenlund KJ, Rith-Najarian S, et al. Association of the insulin resistance syndrome and microalbuminuria among nondiabetic native Americans. The Inter-Tribal Heart Project. J Am Soc Nephrol. 2002;13:1626-1634. (Pubitemid 34579251)
9. Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol. 2005;16:2134-2140. (Pubitemid 41716445)
10. Chen J, Muntner P, Hamm LL, et al. Metabolic syndrome and chronic kidney disease in US Adults. Ann Intern Med. 2004;140:167-174.
11. Ford ES, Giles WH. A comparison of the prevalence of metabolic syndrome using two proposed definitions. Diabetes Care. 2003;26:575-581. (Pubitemid 36929310)
12. Park YW, Zhu S, Palaniappan L, et al. Metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2003;163:427-436. (Pubitemid 36241019)
13. Bosma RJ, van der Heide JJ, Oosterop EJ, et al. Body mass index is associated with altered renal hemodynamics in non-obese healthy subjects. Kidney Int. 2004;65:259-265.
14. Fried LF, Orchard TJ, Kasiske BL. Effect of lipid reduction on the progression of renal disease: a meta-analysis. Kidney Int. 2001;59:260-269. (Pubitemid 32055234)
15. Lea J, Greene T, Hebert L, et al. The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension. Arch Intern Med. 2005;165:947-953. (Pubitemid 40563243)
16. Lea J, Cheek D, Thornley-Brown D, et al. Metabolic syndrome, proteinuria, and the risk of progressive CKD in hypertensive African Americans. Am J Kidney Dis. 2008;51:732-740. (Pubitemid 351626250)
17. Lucove J, Vupputuri S, Heiss G, et al. Metabolic syndrome and the development of CKD in American Indians: the Strong Heart Study. Am J Kidney Dis. 2008;51:21-28. (Pubitemid 350296515)
18. Martins D, Tareen N, Ogedegbe G, et al. The relative risk of cardiovascular death among racial and ethnic minorities with metabolic syndrome: data from the NHANES-II mortality follow-up. J Nat Med Assoc. 2008;100:565-571. (Pubitemid 351717370)
19. Mehrotra R, Kermah D, Fried L, Adler S, Norris K. Racial differences in mortality among those with CKD. J Am Soc Nephrol. 2008;Apr 2 [Epub ahead of print].